Newbury Pharmaceuticals

1,33 SEK

-1,12%

Mindre end 1K følgere

NEWBRY

First North Stockholm

Medical Equipment & Services

Health Care

Kvartalsdata

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Newbury Pharmaceuticals

2024Q1/25Q2/25Q3/25Q4/252025Q1/26Q2/26
Omsætning36,86,512,46,75,931,611,78,5
EBITDA-12,3-3,8-1,0-5,7-5,9-16,3-5,5-3,7
EBIT-14,1-4,2-1,4-6,2-10,1-22,0-6,1-4,1
EBIT-%-38,2 %-64,7 %-11,6 %-92,2 %-171,1 %-69,6 %-52,2 %-49,0 %
Overskud før skat-15,4-4,6-1,9-6,6-10,5-23,6-6,5-4,6
Netto indkomst-15,4-4,6-1,9-6,6-10,8-23,9-6,5-4,6